Vincerx Pharma, Inc.
VINC
$0.8145
$0.00550.68%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -333.79% | 85.45% | -151.09% | 45.04% | 22.02% |
| Total Depreciation and Amortization | 1.85% | 2.27% | 2.33% | 1.57% | 2.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.15% | -177.02% | 1,072.19% | 15.33% | -59.15% |
| Change in Net Operating Assets | -460.80% | 109.57% | 65.78% | -326.60% | 169.19% |
| Cash from Operations | -9.45% | 24.69% | 3.49% | -20.68% | 47.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.48% | -- | -- | -61.82% | 1.74% |
| Cash from Investing | 116.48% | -- | -- | -61.82% | 1.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 339,940.00% | -72.22% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 339,940.00% | -72.22% | -- | -100.00% |
| Foreign Exchange rate Adjustments | 212.50% | -133.33% | 267.44% | -152.94% | -70.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -276.96% | 136.71% | -234.00% | -127.31% | 283.52% |
